Business Information
The group's principal activities are to develop and manufacture therapeutic products, which focus on combating cardiovascular, infectious and oncological diseases. The group operates in two segments: pharmaceuticals and telemedicine. The pharmaceutical segment includes all activities associated with the research, development, manufacture and commercialization of pharmaceutical products. The telemedicine segment includes all activities associated with the research, manufacture and delivery of patient monitoring services. The group also focuses on the development of iminosugar compounds for the treatment of hepatitis b and c.
|
|
Name |
Title
|
Email
|
| Martine Rothblatt | Chmn., CEO | N/A | | Dan Balda | COO, Pres. Medicomp - Inc | N/A | | John Ferrari | CFO, Treasurer | N/A | | Peter Gonze | COO - Unither Pharmaceuticals, Inc | N/A | | Roger Jeffs | Dir., COO, Pres. | N/A |
|
|
Year |
Sales |
Net Income |
| 2006 | 159,632 | 73,965 | | 2005 | 115,915 | 65,016 | | 2004 | 73,590 | 15,449
|
|
| TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
TO SEE COMPLETE RESULTS SUBSCRIBE NOW |
|
Click for more Executives |
|
|
